U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H8O2
Molecular Weight 136.1479
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENYL ACETATE

SMILES

CC(=O)OC1=CC=CC=C1

InChI

InChIKey=IPBVNPXQWQGGJP-UHFFFAOYSA-N
InChI=1S/C8H8O2/c1-7(9)10-8-5-3-2-4-6-8/h2-6H,1H3

HIDE SMILES / InChI

Molecular Formula C8H8O2
Molecular Weight 136.1479
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Phenylacetate is the ester of a phenol and acetic acid. It is a metabolite of anticancer drug phenylbutyrate (PB), natural neurotransmitter phenylethylamine. Naturally, it is an odorant found in strawberries, passion fruit, and black tea. Phenylacetate level in urine was used as a marker for the diagnosis of some forms of unipolar major depressive disorders. Phenylacetate is used as a tool substrate to study esterase activity in the blood of patients in clinical studies of the effect of nutritional supplements on paraoxonase-1 levels.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver.
1999 Jun
Hydrolysis of platelet-activating factor by human serum paraoxonase.
2001 Feb 15
Aspirin. An ab initio quantum-mechanical study of conformational preferences and of neighboring group interactions.
2001 Feb 9
Tyrosine and phenylalanine catabolism by Lactobacillus cheese flavor adjuncts.
2001 May
Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.
2002
Olfactory discrimination ability for aromatic odorants as a function of oxygen moiety.
2002 Jan
Monitoring of enzymatic hydrolysis of penicillin G by pyrolysis-negative ion mass spectrometry.
2002 Jul 1
[The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus].
2002 Mar
Fast, easy, and efficient method for the purification of phenolic isomers using a selective solid-phase scavenging process.
2002 Nov-Dec
The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
2003
Europium ion catalyzed methanolysis of esters at neutral pH and ambient temperature. catalytic Involvement of Eu3+(CH3O-)(CH3OH)x.
2003 Jan 13
Observation of an arsenic adduct in an acetyl esterase crystal structure.
2003 Jan 17
Environmental fate and bioavailability of Agent Orange and its associated dioxin during the Vietnam War.
2004
Purification, substrate specificity, and N-terminal amino acid sequence analysis of a beta-lactamase-free penicillin amidase from Alcaligenes sp.
2004 Aug
[Decrease of paraoxonase activity in the first day after abdominal operations in women].
2004 Jul
A new class of acyclic 2-alkyl-1,1,2-triaryl (Z)-olefins as selective cyclooxygenase-2 inhibitors.
2004 Nov 18
Isolation of three new naturally occurring compounds from the culture of Micromonospora sp. P1068.
2005 Oct
Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
2006
Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.
2006 Aug
Polymer supported vanadium and molybdenum complexes as potential catalysts for the oxidation and oxidative bromination of organic substrates.
2006 Aug 7
High yield recombinant penicillin G amidase production and export into the growth medium using Bacillus megaterium.
2006 Nov 28
Nanostructured biosensor for measuring neuropathy target esterase activity.
2007 Jul 15
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
2007 Jun
The distribution of esterases in the skin of the minipig.
2007 Sep 10
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.
2008 Apr
Simple procedures for purification and stabilization of human serum paraoxonase-1.
2008 Apr 24
Topical ocular delivery of NSAIDs.
2008 Jun
Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator.
2008 Oct
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
2008 Oct 16
Effect of 7Li radiation on endogenous hormonal level on developing cotton fiber.
2008 Sep
Modulation of butyrate transport in Caco-2 cells.
2009 Apr
Determinants of variation in human serum paraoxonase activity.
2009 Feb
Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives.
2009 Jun
High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.
2009 Nov
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.
2009 Nov 17
Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.
2009 Nov 3
Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.
2009 Oct
Effect of loading rate and HRT on the removal of cephalosporin and their intermediates during the operation of a membrane bioreactor treating pharmaceutical wastewater.
2009 Sep
Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.
2009 Sep 9
3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway.
2010 Feb 12
A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota.
2010 Jun
Synthesis of cholesterol-conjugated magnetic nanoparticles for purification of human paraoxonase 1.
2010 Oct
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Arylesterase activity was measured as the rate of hydrolysis of phenylacetate into phenol. This process can be detected spectrophotometrically. Serum samples were prepared in sample buffer consisting of 20 mM Tris and 0.9 mM CaCl2 (pH 8.0) in a 40-fold dilution. Five ul of diluted serum was then added to 200 ul of freshly made substrate buffer containing 1 mM phenylacetate, 20 mM Tris, and 0.9 mM CaCl2. The reaction was monitored on a microtiter plate at 260 nm in a Fluostar microplate reader at 37°C. The nonenzymatic hydrolysis of phenylacetate, based on the hydrolysis rate in the absence of serum, was subtracted from the total rate of hydrolysis.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:04:28 GMT 2023
Edited
by admin
on Fri Dec 15 15:04:28 GMT 2023
Record UNII
355G9R500Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENYL ACETATE
FHFI   HSDB   MI  
Systematic Name English
PHENYL ACETATE [HSDB]
Common Name English
ACETIC ACID, PHENYL ESTER
Common Name English
PHENYLACETATE
Systematic Name English
PHENYL ACETATE [FHFI]
Common Name English
PHENYL ACETATE [MI]
Common Name English
NSC-27795
Code English
FEMA NO. 3958
Code English
ACETOXYBENZENE
Systematic Name English
(ACETYLOXY)BENZENE
Systematic Name English
PHENOL ACETATE
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 77993
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
FDA ORPHAN DRUG 110698
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
NCI_THESAURUS C1934
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
FDA ORPHAN DRUG 11385
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
LOINC 75062-0
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
JECFA EVALUATION PHENYL ACETATE
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
Code System Code Type Description
CAS
122-79-2
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
RXCUI
70619
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID3051626
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
CHEBI
8082
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
ECHA (EC/EINECS)
204-575-0
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
MERCK INDEX
m8649
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C1501
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
JECFA MONOGRAPH
605
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
EVMPD
SUB181406
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
WIKIPEDIA
PHENYL ACETATE
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
HSDB
2667
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
PUBCHEM
31229
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
NSC
27795
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
CHEBI
18401
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
FDA UNII
355G9R500Y
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY
SMS_ID
100000167072
Created by admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
PRIMARY